View ValuationTransoceanic Investments 将来の成長Future 基準チェック /06現在、 Transoceanic Investmentsの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Metals and Mining 収益成長18.5%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Oct 06Mason Resources Inc., Annual General Meeting, Dec 16, 2025Mason Resources Inc., Annual General Meeting, Dec 16, 2025.お知らせ • Jan 14Mason Resources Inc. announced that it has received CAD 1.4 million in fundingOn January 13, 2025,Mason Resources Inc. closed the transaction, The Company is pleased to confirm that Fahad Al Tamimi, subscribed to 6,980,000 Units under the Offering which has resulted in an increase in his ownership stake to approximately 19.2% on a partially diluted basis. The securities issued are subject to a regulatory hold period that expires on May 14, 2025. Closing remains subject to final approval of the TSX Venture Exchange. Insiders of the Company subscribed for 24.9% of the Offering.お知らせ • Oct 08Mason Resources Inc., Annual General Meeting, Dec 19, 2024Mason Resources Inc., Annual General Meeting, Dec 19, 2024.Board Change • Aug 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. Independent Director Adree Delazzer was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Apr 30Mason Resources Inc. Underscores Black Swan Graphene's Launch of Graphene-Enhanced Commercial MasterbatchesMason Resources Inc. announced that congratulates Black Swan Graphene on the successful launch of their Graphene-Enhanced Commercial Masterbatches. Black Swan's graphene enhanced masterbatch products, GraphCore, offer price-performance improvements without any supply chain disruption and are available in volume both directly from Black Swan or through globally represented value-added distributors: Thomas Swan & Co LTD, Gerdau Graphene, and Hubron International. Black Swan is now carrying out external industrial trials in masterbatch in a range of different polymers, including TPU, Nylon (PA6/66), PLA, HDPE, LDPE, PET, PC & PP.お知らせ • Jan 24Nouveau Monde Graphite Inc. (TSXV:NOU) entered into an asset purchase agreement to acquire Lac Guéret graphite from Mason Resources Inc. (TSXV:LLG) for CAD 23.6 million.Nouveau Monde Graphite Inc. (TSXV:NOU) entered into an asset purchase agreement to acquire Lac Guéret graphite from Mason Resources Inc. (TSXV:LLG) for CAD 23.6 million on January 21, 2024. The consideration for the acquisition of the Lac Guéret Property is payable in 6,208,210 Nouveau Monde Graphite shares. subsequent payment of $5 million will be made to Mason at the start of commercial production of the contemplated Uatnan Mining Project. 3,104,105 of the common shares of Nouveau Monde Graphite to be issued in connection with the transaction will be subject to a lock-up for a period of 12 months and the remaining 3,104,105 common shares of Nouveau Monde Graphite will be subject to a lock-up of 18 months. Closing of the transaction is expected to occur on or before January 31, 2024, and is subject to certain standard conditions, including the receipt of the final approval from the TSX Venture Exchange.Board Change • Nov 22High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Adree Delazzer was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.New Risk • Oct 28New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next year. Trailing 12-month net loss: CA$5.6m Forecast net loss in 1 year: CA$1.9m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Earnings have declined by 3.6% per year over the past 5 years. Revenue is less than US$1m. Minor Risks Currently unprofitable and not forecast to become profitable next year (CA$1.9m net loss next year). Market cap is less than US$100m (€25.1m market cap, or US$26.5m).お知らせ • Oct 06Mason Graphite Inc., Annual General Meeting, Dec 19, 2023Mason Graphite Inc., Annual General Meeting, Dec 19, 2023.お知らせ • Aug 02+ 1 more updateFahad Al-Tamimi acquired 4.53% stake in Mason Graphite Inc. (TSXV:LLG) for CAD 1.5 million.Fahad Al-Tamimi acquired 4.53% stake in Mason Graphite Inc. (TSXV:LLG) for CAD 1.5 million on August 1, 2023. Prior to the transaction, Fahad Al-Tamimi owned 13.52 million shares, representing approximately 9.57% of Mason Graphite's issued and outstanding shares. Following the transaction, Fahad Al-Tamimi owns 19.92 million shares, representing approximately 14.1% of the Company's issued and outstanding shares. Fahad Al-Tamimi completed the acquisition of 4.53% stake in Mason Graphite Inc. (TSXV:LLG) on August 1, 2023.Board Change • Nov 16High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. President, CEO, Corporate Secretary & Executive Director Peter Damouni is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Board Change • Apr 28Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. 2 independent directors (4 non-independent directors). Executive Director Peter Damouni is the most experienced director on the board, commencing their role in 2020. Lead Independent Director Tayfun Eldem was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Director Overboarding • Aug 07Director Peter Damouni has joined 7th company boardPeter Damouni has been appointed to the board of XPhyto Therapeutics Corp. (CNSX:XPHY). Damouni now sits on a total of 7 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.Director Overboarding • Aug 07Director Peter Damouni has joined 7th company boardPeter Damouni has been appointed to the board of XPhyto Therapeutics Corp. (CNSX:XPHY). Damouni now sits on a total of 7 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.Director Overboarding • Aug 07Director Peter Damouni has joined 7th company boardPeter Damouni has been appointed to the board of XPhyto Therapeutics Corp. (CNSX:XPHY). Damouni now sits on a total of 7 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.Director Overboarding • Aug 07Director Peter Damouni has joined 7th company boardPeter Damouni has been appointed to the board of XPhyto Therapeutics Corp. (CNSX:XPHY). Damouni now sits on a total of 7 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.Director Overboarding • Aug 07Director Peter Damouni has joined 7th company boardPeter Damouni has been appointed to the board of XPhyto Therapeutics Corp. (CNSX:XPHY). Damouni now sits on a total of 7 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.Director Overboarding • Aug 07Director Peter Damouni has joined 7th company boardPeter Damouni has been appointed to the board of XPhyto Therapeutics Corp. (CNSX:XPHY). Damouni now sits on a total of 7 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.Is New 90 Day High Low • Feb 21New 90-day high: €0.68The company is up 184% from its price of €0.24 on 20 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Metals and Mining industry, which is up 66% over the same period.Is New 90 Day High Low • Feb 04New 90-day high: €0.49The company is up 187% from its price of €0.17 on 06 November 2020. The German market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Metals and Mining industry, which is up 67% over the same period.Is New 90 Day High Low • Jan 14New 90-day high: €0.32The company is up 109% from its price of €0.15 on 16 October 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Metals and Mining industry, which is up 60% over the same period.Is New 90 Day High Low • Nov 13New 90-day high: €0.20The company is up 96% from its price of €0.10 on 14 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Metals and Mining industry, which is up 2.0% over the same period. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Transoceanic Investments は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測DB:3SB - アナリストの将来予測と過去の財務データ ( )CAD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/2026N/A12-2-2N/A12/31/2025N/A12-7-7N/A9/30/2025N/A19-1-1N/A6/30/2025N/A-5-1-1N/A3/31/2025N/A-6-1-1N/A12/31/2024N/A-7-2-2N/A9/30/2024N/A-7-2-2N/A6/30/2024N/A-2-2-2N/A3/31/2024N/A-3-3-3N/A12/31/2023N/A-5-2-2N/A9/30/2023N/A-5-3-3N/A6/30/2023N/A-6-3-3N/A3/31/2023N/A-6-4-3N/A12/31/2022N/A-6-5-5N/A9/30/2022N/A-5-6-5N/A6/30/2022N/A-3-12-5N/A3/31/2022N/A-3-11-4N/A12/31/2021N/A-5-12-5N/A9/30/2021N/A-6-11-5N/A6/30/2021N/A-7-7-5N/A3/31/2021N/A-10-10-6N/A12/31/2020N/A-48-8-4N/A9/30/2020N/A-46-9-4N/A6/30/2020N/A-26-11-4N/A3/31/2020N/A-24-11-3N/A12/31/2019N/A18N/A-3N/A9/30/2019N/A18N/A-3N/A6/30/2019N/A1N/A-4N/A3/31/2019N/A3N/A-5N/A12/31/2018N/A3N/A-5N/A9/30/2018N/A2N/A-5N/A6/30/2018N/A-1N/A-5N/A3/31/2018N/A-4N/A-4N/A12/31/2017N/A-8N/A-4N/A9/30/2017N/A-7N/A-4N/A6/30/2017N/A-9N/A-4N/A3/31/2017N/A-7N/A-3N/A12/31/2016N/A-5N/A-2N/A9/30/2016N/A-6N/A-2N/A6/30/2016N/A-4N/A-1N/A3/31/2016N/A-3N/A-2N/A12/31/2015N/A-4N/A-2N/A9/30/2015N/A-4N/A-2N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 3SBの予測収益成長が 貯蓄率 ( 1.9% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 3SBの収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 3SBの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 3SBの収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 3SBの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 3SBの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/17 04:00終値2026/06/17 00:00収益2026/03/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Transoceanic Investments Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関Ahmad ShaathBeacon Securities LimitedDaniel GreenspanMacquarie ResearchRupert MererNational Bank Financial1 その他のアナリストを表示
お知らせ • Oct 06Mason Resources Inc., Annual General Meeting, Dec 16, 2025Mason Resources Inc., Annual General Meeting, Dec 16, 2025.
お知らせ • Jan 14Mason Resources Inc. announced that it has received CAD 1.4 million in fundingOn January 13, 2025,Mason Resources Inc. closed the transaction, The Company is pleased to confirm that Fahad Al Tamimi, subscribed to 6,980,000 Units under the Offering which has resulted in an increase in his ownership stake to approximately 19.2% on a partially diluted basis. The securities issued are subject to a regulatory hold period that expires on May 14, 2025. Closing remains subject to final approval of the TSX Venture Exchange. Insiders of the Company subscribed for 24.9% of the Offering.
お知らせ • Oct 08Mason Resources Inc., Annual General Meeting, Dec 19, 2024Mason Resources Inc., Annual General Meeting, Dec 19, 2024.
Board Change • Aug 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. Independent Director Adree Delazzer was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 30Mason Resources Inc. Underscores Black Swan Graphene's Launch of Graphene-Enhanced Commercial MasterbatchesMason Resources Inc. announced that congratulates Black Swan Graphene on the successful launch of their Graphene-Enhanced Commercial Masterbatches. Black Swan's graphene enhanced masterbatch products, GraphCore, offer price-performance improvements without any supply chain disruption and are available in volume both directly from Black Swan or through globally represented value-added distributors: Thomas Swan & Co LTD, Gerdau Graphene, and Hubron International. Black Swan is now carrying out external industrial trials in masterbatch in a range of different polymers, including TPU, Nylon (PA6/66), PLA, HDPE, LDPE, PET, PC & PP.
お知らせ • Jan 24Nouveau Monde Graphite Inc. (TSXV:NOU) entered into an asset purchase agreement to acquire Lac Guéret graphite from Mason Resources Inc. (TSXV:LLG) for CAD 23.6 million.Nouveau Monde Graphite Inc. (TSXV:NOU) entered into an asset purchase agreement to acquire Lac Guéret graphite from Mason Resources Inc. (TSXV:LLG) for CAD 23.6 million on January 21, 2024. The consideration for the acquisition of the Lac Guéret Property is payable in 6,208,210 Nouveau Monde Graphite shares. subsequent payment of $5 million will be made to Mason at the start of commercial production of the contemplated Uatnan Mining Project. 3,104,105 of the common shares of Nouveau Monde Graphite to be issued in connection with the transaction will be subject to a lock-up for a period of 12 months and the remaining 3,104,105 common shares of Nouveau Monde Graphite will be subject to a lock-up of 18 months. Closing of the transaction is expected to occur on or before January 31, 2024, and is subject to certain standard conditions, including the receipt of the final approval from the TSX Venture Exchange.
Board Change • Nov 22High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Adree Delazzer was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
New Risk • Oct 28New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next year. Trailing 12-month net loss: CA$5.6m Forecast net loss in 1 year: CA$1.9m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Earnings have declined by 3.6% per year over the past 5 years. Revenue is less than US$1m. Minor Risks Currently unprofitable and not forecast to become profitable next year (CA$1.9m net loss next year). Market cap is less than US$100m (€25.1m market cap, or US$26.5m).
お知らせ • Oct 06Mason Graphite Inc., Annual General Meeting, Dec 19, 2023Mason Graphite Inc., Annual General Meeting, Dec 19, 2023.
お知らせ • Aug 02+ 1 more updateFahad Al-Tamimi acquired 4.53% stake in Mason Graphite Inc. (TSXV:LLG) for CAD 1.5 million.Fahad Al-Tamimi acquired 4.53% stake in Mason Graphite Inc. (TSXV:LLG) for CAD 1.5 million on August 1, 2023. Prior to the transaction, Fahad Al-Tamimi owned 13.52 million shares, representing approximately 9.57% of Mason Graphite's issued and outstanding shares. Following the transaction, Fahad Al-Tamimi owns 19.92 million shares, representing approximately 14.1% of the Company's issued and outstanding shares. Fahad Al-Tamimi completed the acquisition of 4.53% stake in Mason Graphite Inc. (TSXV:LLG) on August 1, 2023.
Board Change • Nov 16High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. President, CEO, Corporate Secretary & Executive Director Peter Damouni is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Board Change • Apr 28Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. 2 independent directors (4 non-independent directors). Executive Director Peter Damouni is the most experienced director on the board, commencing their role in 2020. Lead Independent Director Tayfun Eldem was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Director Overboarding • Aug 07Director Peter Damouni has joined 7th company boardPeter Damouni has been appointed to the board of XPhyto Therapeutics Corp. (CNSX:XPHY). Damouni now sits on a total of 7 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.
Director Overboarding • Aug 07Director Peter Damouni has joined 7th company boardPeter Damouni has been appointed to the board of XPhyto Therapeutics Corp. (CNSX:XPHY). Damouni now sits on a total of 7 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.
Director Overboarding • Aug 07Director Peter Damouni has joined 7th company boardPeter Damouni has been appointed to the board of XPhyto Therapeutics Corp. (CNSX:XPHY). Damouni now sits on a total of 7 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.
Director Overboarding • Aug 07Director Peter Damouni has joined 7th company boardPeter Damouni has been appointed to the board of XPhyto Therapeutics Corp. (CNSX:XPHY). Damouni now sits on a total of 7 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.
Director Overboarding • Aug 07Director Peter Damouni has joined 7th company boardPeter Damouni has been appointed to the board of XPhyto Therapeutics Corp. (CNSX:XPHY). Damouni now sits on a total of 7 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.
Director Overboarding • Aug 07Director Peter Damouni has joined 7th company boardPeter Damouni has been appointed to the board of XPhyto Therapeutics Corp. (CNSX:XPHY). Damouni now sits on a total of 7 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.
Is New 90 Day High Low • Feb 21New 90-day high: €0.68The company is up 184% from its price of €0.24 on 20 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Metals and Mining industry, which is up 66% over the same period.
Is New 90 Day High Low • Feb 04New 90-day high: €0.49The company is up 187% from its price of €0.17 on 06 November 2020. The German market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Metals and Mining industry, which is up 67% over the same period.
Is New 90 Day High Low • Jan 14New 90-day high: €0.32The company is up 109% from its price of €0.15 on 16 October 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Metals and Mining industry, which is up 60% over the same period.
Is New 90 Day High Low • Nov 13New 90-day high: €0.20The company is up 96% from its price of €0.10 on 14 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Metals and Mining industry, which is up 2.0% over the same period.